Emergency Use Authorization of the World’s First Plasmid DNA COVID-19 Vaccine Delivered Exclusively with the PharmaJet Needle-free Injection System
In August 2021, Zydus Cadila received Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D, the world’s first plasmid DNA Vaccine for COVID-19. The vaccine, for those 12 years and above, is exclusively administered using the PharmaJet Tropis® Needle-free Injection System. Plans are moving forward to manufacture 80+ million doses of the ZyCoV-D vaccine in South Korea to be exported to several lower-middle income countries in Latin America and Asia.
COVID-19 Vaccine Partnerships
Click on image to enlarge